Delivery Order SPE2DR25D2205-SPE2DR26F1S91
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,367.44 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. The contract, issued on December 16, 2025, is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,111.33 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on January 6, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of January 28, 2026. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This award was made on a non-set-aside, competitive basis and represents a task...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $14,170.66 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. The contract, awarded on December 15, 2025, carries a firm fixed price structure with an ultimate completion date of January 7, 2026. This is a non-set-aside competitive award to be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $4,211.84 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is competitively awarded with no set-aside designation. The contract represents a child award under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,212.04 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitive award with an ultimate completion date of September 22, 2025. The contract represents a child delivery order under AmerisourceBergen's broader relationship with DLA, leveraging the company's extensive pharmaceutical distribution...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Varivax vaccine with diluents valued at $10,321.10 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on June 30, 2025. The contract is set to complete by July 22, 2025, and represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) for the supply of Varivax vaccine with diluents. The award, issued on July 7, 2025, with an ultimate completion date of July 28, 2025, carries a firm fixed price structure and represents a competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,111.33 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on December 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of January 23, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This award was...
- The Defense Logistics Agency has awarded a delivery order valued at $1,012.19 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of January 12, 2026. The vaccine will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,039.38 on November 28, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 19, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1S91Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $55,008.50 by the Defense Logistics Agency (DLA) on January 6, 2026, for the supply of Varivax vaccine with diluents. The order will be completed by January 28, 2026, with performance at the company's headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and falls under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. Amerisourcebergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, regularly fulfilling medical procurement needs for military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contracting portfolio encompasses a wide range of pharmaceutical products, vaccines, and medical devices across multiple therapeutic domains. This Varivax vaccine delivery order supports DLA's mission to provide essential immunization products to Department of Defense healthcare facilities and personnel worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.0k | 1/5/26 |